If you need more lookups,
subscriptions start at $34 USD/month.
Steve Chin Location
Shanghai, CN
Steve Chin Work
Chief Medical Officer @ (October 2023 - Present)
Chief Medical Officer @ (January 2020 - October 2023)
Senior Medical Director, Immuno-Oncology, Global Clinical Development @ (May 2018 - January 2020)
Global and US GI Oncology Lead @ Eli Lilly and Company (December 2017 - May 2018)
US Medical Lead, GI and H and N Oncology @ Eli Lilly and Company (July 2014 - December 2017)
Assistant Professor @ (September 2008 - July 2014)
GI Medical Oncology @ Holling Cancer Center (September 2008 - July 2014)
Assistant Professor @ (July 2005 - September 2008)
Steve Chin Education
Boston University
Penn State College of Medicine
Wayne State University School of Medicine
Steve Chin Skills
Biologics
Biotechnology
Cancer
Cancer Immunotherapy
Cancer Research
Clinical Development
Clinical Research
Clinical Trials
Cross-cultural Communication Skills
Cross-functional Team Leadership
Drug Development
Drug Discovery
Healthcare
Internal Medicine
Life Sciences
Medical Education
Medical Writing
Medicine
Monoclonal Antibodies
Oncology
Oncology Clinical Research
Pharmaceutical Industry
Product Development
Product Launch
Regulatory Submissions
Research
Strategic Planning
Targeted Therapies
Cross Functional Team Leadership
Sales
Cross Cultural Communication Skills
Steve Chin Summary
Steve Chin, based in Shanghai, CN, is currently a Chief Medical Officer at MediLink Therapeutics. Steve Chin brings experience from previous roles at Elpiscience Biopharmaceuticals, Inc., AstraZeneca and Eli Lilly and Company. Steve Chin holds a Boston University. With a robust skill set that includes Biologics, Biotechnology, Cancer, Cancer Immunotherapy, Cancer Research and more. Steve Chin has 5 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Steve Chin?
Find contact details for 700 million professionals.